by Sara M. Nolte | Jun 9, 2014
> I recently wrote about the dilemma many cancer stem cell (CSC) researchers face when trying to model their disease of interest in the lab. So assuming a researcher has successfully chosen their model – what happens next? Allow me to introduce to you some of the...
by Lisa Willemse | Jun 6, 2014
> Cycling season is in full gear and for the rapidly growing number of enthusiasts, it means many miles on tarmac and trail, Strava leaderboard competitions and various degrees of obsession with the world’s major races. I’m not much of a road rider...
by Mark Curtis | May 14, 2014
. Welcome to your RM deal review for the month of April. There were two notable acquisitions this past month. NeoStem entered into an agreement to acquire California Stem Cell, while Aastrom acquired Sanofi’s regenerative medicine business. Read on to find out more....
by Holly Wobma | May 13, 2014
> I think one of the most universally embraced ideas when people gather together and pontificate about how their relatives or colleagues turned out they way they did, is that ‘people are a product of their environment’. I’m not here to make a singular stand against...
by Stacey Johnson | May 2, 2014
. May is the month that students learn whether they’ve been accepted into medical programs at Canadian universities. Good luck kids! Good luck parents! This infographic, on the evolution of medicine, comes courtesy of BestMedicalDegrees.com, an independent online...
by Lisa Willemse | Apr 25, 2014
> Julia Pon is a MD/PhD student at the University of British Columbia with an interest in blood cancer. Like many before her, she noticed that the kind of information that is shared with cancer patients is different than what medical students are taught about the...
Comments